copay coupons

November 29, 2011 -- The proliferation of brand drug “copay coupon” promotions, which lure insured consumers from generics to more expensive brands, will increase costs by $338 million in Oregon over the next decade for employers, unions, and state employee plans, according to new research from Visante and released by the Pharmaceutical Care Management Association (PCMA). The use of these promotions by state and local government workers alone will cost Oregon taxpayers an extra $58 million over ten years.